FP7-PEOPLE-2011-CIG
FP7-PEOPLE-2011-CIG
Programme: FP7
469 projects · €43,983,333 total EU contribution (project-level) · 260 participating organizations · 32 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€43,983,333
Countries active
Participant organizations by country (headquarters in CORDIS).
- Spain (47)
- Germany (31)
- UK (20)
- France (19)
- TR (19)
- Italy (17)
- Netherlands (16)
- EL (10)
- IL (10)
- AT (7)
- BE (7)
- SE (6)
- CH (5)
- CZ (5)
- FI (5)
- HU (5)
- PT (5)
- IE (4)
- PL (4)
- DK (3)
- BG (2)
- RO (2)
- CY (1)
- HR (1)
- IS (1)
- LT (1)
- LU (1)
- MT (1)
- NO (1)
- RS (1)
- SI (1)
- SK (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- CSIC22 projects · ES
- CNRS18 projects · FR
- BGU13 projects · IL
- TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY11 projects · IL
- TAU11 projects · IL
- INSERM8 projects · FR
- UNIVLEEDS7 projects · UK
- BOGAZICI UNIVERSITESI6 projects · TR
- UCPH6 projects · DK
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5 projects · UK
- REICHMAN UNIVERSITY5 projects · IL
- SABANCI UNIVERSITY5 projects · TR
Projects
Page 4 of 47
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Marketing Strategy Implementation as Source of Firms´ Competitive Advantage IMS · 294260 | FP7 | €100,000 | €100,000 | Details |
Substrate specificity, mechanism and biological roles of rhomboid intramembrane proteases. RHOMBOID SUBSTRATES · 304154 | FP7 | €100,000 | €100,000 | Details |
Protecting biodiversity in the face of climate change PROTECTINGBIOFACCTS · 293886 | FP7 | €100,000 | €100,000 | Details |
Development of a Bioengineered Heart Patch for the Treatment of Myocardial Infarction HEART PATCH · 304209 | FP7 | €100,000 | €100,000 | Details |
Transcriptional regulation of IL-9-producing CD4 T cells: use in cancer immunotherapy T9CAN · 303719 | FP7 | €100,000 | €100,000 | Details |
Biophysics of Reverse Transcription and its Inhibition BIOPHYSRETRAIN · 293923 | FP7 | €100,000 | €100,000 | Details |
The Cognitive Neuroscience of Deception COND · 293850 | FP7 | €100,000 | €100,000 | Details |
METABOLIC CONTROL OF IMMATURE STROMAL CELL BIOLOGY METABOSTEM · 293720 | FP7 | €75,000 | €75,000 | Details |
Enabling Seismic Design Decision-Making under Uncertainty IDESIGN · 293855 | FP7 | €100,000 | €100,000 | Details |
Improving Protein Homeostasis to Extend Health- and Lifespan ER LONGEVITY · 303714 | FP7 | €100,000 | €100,000 | Details |